Given recent advances in DR treatment, trends in better systemic clinical management of diabetes, improved patient education, and the high prevalence of diabetes worldwide, it would be reasonable to project an increasing trend in the number of patients with mild DR in the coming decades.
← all excerpts
Report From the NEI/FDA Diabetic Retinopathy Clinical Trial Design and Endpoints Workshop.
1
—
—